Literature DB >> 6169197

Mechanism of interferon action: cloned human leukocyte interferons induce protein kinase and inhibit vesicular stomatitis virus but not reovirus replication in human amnion cells.

C E Samuel, G S Knutson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1981        PMID： 6169197     DOI： 10.1016/0042-6822(81)90282-8

Source DB:  PubMed          Journal:  Virology        ISSN： 0042-6822            Impact factor:   3.616


× No keyword cloud information.
  5 in total

1.  An adenovirus mutant unable to express VAI RNA displays different growth responses and sensitivity to interferon in various host cell lines.

Authors:  J Kitajewski; R J Schneider; B Safer; T Shenk
Journal:  Mol Cell Biol       Date:  1986-12       Impact factor: 4.272

2.  RNA editing enzyme adenosine deaminase is a restriction factor for controlling measles virus replication that also is required for embryogenesis.

Authors:  Simone V Ward; Cyril X George; Megan J Welch; Li-Ying Liou; Bumsuk Hahm; Hanna Lewicki; Juan C de la Torre; Charles E Samuel; Michael B Oldstone
Journal:  Proc Natl Acad Sci U S A       Date:  2010-12-20       Impact factor: 11.205

3.  Double-stranded RNA-dependent phosphorylation of protein P1 and eukaryotic initiation factor 2 alpha does not correlate with protein synthesis inhibition in a cell-free system from interferon-treated mouse L cells.

Authors:  H Jacobsen; D A Epstein; R M Friedmann; B Safer; P F Torrence
Journal:  Proc Natl Acad Sci U S A       Date:  1983-01       Impact factor: 11.205

4.  RNA adenosine deaminase ADAR1 deficiency leads to increased activation of protein kinase PKR and reduced vesicular stomatitis virus growth following interferon treatment.

Authors:  Zhiqun Li; Karen C Wolff; Charles E Samuel
Journal:  Virology       Date:  2009-11-12       Impact factor: 3.616

5.  Protein kinase PKR plays a stimulus- and virus-dependent role in apoptotic death and virus multiplication in human cells.

Authors:  Ping Zhang; Charles E Samuel
Journal:  J Virol       Date:  2007-05-23       Impact factor: 5.103
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.